• Products
  • Patients
  • Providers
  • About Us
  • Contact
  • Customers
  • Virtual Booth
  • News
  • Media
  • Events
  • Careers
  • Search
  • Toggle side navigation
  • Virtual Booth
  • News
  • Media
  • Events
  • Careers

Optos AMD Solutions

 

Find Out More

 

Early detection of age-related macular degeneration (AMD) offers an
opportunity to intervene early in the course of disease.

Our unique program is aimed at preventing vision loss due to dry AMD. Using new technology to find, test and treat, the program offers patients with dry AMD the hope of years of good vision.

Optos AMD Solutions is based on two powerful technologies:

 

AMD Solutions


optomap® Ultra-widefield Retinal Imaging

Ultra-widefield imaging has been shown to contribute to the benefits in the diagnosis and management of AMD.

Using ultra-widefield optomap colour and autofluorescence retinal images as part of your comprehensive ocular health. In partnership with Valeda, Optos has created a new program aimed at preventing vision loss due to Dry AMD. Studies have shown that AMD may be more than a “macular” condition but one that involves the entire retina.

Using new technology to find, test, and treat dry AMD this program offers patients with Dry AMD the hope of years of good vision.

The Benefits of optomap

How an optomap image is captured

AMD Clinical Case study

A Vision for a Brighter Future

ValedaTM Light Delivery System

First approved treatment for Dry Age-Related Macular Degeneration using photobiomodulation. Valeda is a platform with the potential to successfully treat a number of degenerative ocular diseases. The Valeda Light Delivery System is the first and only approved treatment for dry AMD using photobiomodulation (PBM), creating a brighter horizon for patients by developing treatment solutions to improve visual function, stop or slow the progression of debilitating eye diseases and prevent vision loss and blindness.

Valeda was designed for ease of use in the doctor’s surgery

Under the doctor’s supervision, trained staff are able to administer the Valeda treatment.

  • Excellent safety profile
  • Preserves future treatment options

Treatments are delivered in a series of 9 sessions per eye over a three-week period. Each treatment session lasts less than 5 minutes per eye.

 

Learn More

Valeda Brochure

Introducing Valeda Light Delivery System

Would you like to know more? Please complete the form below and a member of our team will be in touch shortly.

You are now leaving the Global site. To change your language, make a selection at the bottom of the page.

Ok Cancel

You are now leaving the Global site. To change your language, make a selection at the bottom of the page.

Ok Cancel
Deutsch Français
English
  • Distributor Portal
  • Find a Doctor
  • Registered in Scotland
  • Blog
  • Unsubscribe
  • Manage Preferences
  • Privacy
  • UK Modern Slavery Act
  • Cookie Policy

© 2021 Optos. Optos, optos and optomap are registered trademarks of Optos plc. UWF is an Optos trademark.